Crosscheck

Your medical. Crosschecked.

Check another medication

Cholesterol

Mipomersen and your FAA medical

Apolipoprotein B antisense oligonucleotide
Other names: Kynamro

FAA guidance

Do not issue.

Examiner

Do not issue: the examiner cannot issue a certificate

FAA label

UNACCEPTABLE

Source: FAA, Cholesterol Medication. FAA date 27 August 2025. Checked by Crosscheck 11 November 2026

The FAA lists mipomersen as an unacceptable cholesterol medication.

Track your medications
Show the FAA's words: mipomersenThe official FAA wording: one passage, each with its document and dateOpen
FAA, Cholesterol Medication · FAA date 27 August 2025
UNACCEPTABLE Cholesterol Medications. Apolipoprotein B Antisense Oligonucleotide: mipomersen (Kynamro)
Sources and dates: mipomersenOne FAA document, with the FAA's date and when Crosscheck checked itOpen

Questions pilots ask

Each answer is built from the FAA guidance on this page. Its sources and dates are in the page.

What does the FAA say about mipomersen for pilots?

FAA guidance: Do not issue. The FAA lists mipomersen as an unacceptable cholesterol medication. Crosscheck does not predict the FAA's decision.

What does the examiner do for mipomersen?

Do not issue: the examiner cannot issue a certificate. Crosscheck does not predict the FAA's decision.

Related pages

Medication guidance alone does not determine whether a pilot is medically qualified to fly. The underlying condition, dosage, side effects, medication combinations, and certification history may affect FAA eligibility.

For informational purposes only. Not legal or medical advice.